ipamorelin clinical trial 2025 monarchE at ESMO 2025: Adjuvant Abemaciclib Plus Endocrine Therapy Improves Overall Survival in High-Risk HR+, HER2− Early Breast Cancer Needs Optimization CHRONIC FATIGUE SYNDROME/MYALGIC ENCEPHALOMYELITIS, quantity:3

ipamorelin clinical trial 2025 monarchE at ESMO 2025: Adjuvant Abemaciclib Plus Endocrine Therapy Improves Overall Survival in High-Risk HR+, HER2− Early Breast Cancer Needs Optimization CHRONIC FATIGUE SYNDROME/MYALGIC ENCEPHALOMYELITIS, quantity:3

CHRONIC FATIGUE SYNDROME/MYALGIC ENCEPHALOMYELITIS, FIBROMYALGIA,... | Download Scientific Diagram

doi: 10.1126/science.abf9277

Needs Optimization

quantity:3

Results Genetically predicted l-carnitine was nominally associated with higher risk of CAD overall (OR 1.07 per standard deviation (SD) increase in l-carnitine, 95% CI 1.02 to 1.11) and in men (OR 1.09, 95% CI 1.02 to 1.16) but had a null association in women (OR 1.00, 95% CI 0.92 to 1.09)